Profile
Rachel Belsham is currently working as an Operating Advisor at Revival Healthcare Capital LLC.
Prior to this, she worked as an Executive Vice President-Strategic Development at Visa Europe Ltd. She completed her undergraduate degree from the University of Oxford in 1989.
Rachel Belsham active positions
| Companies | Position | Start |
|---|---|---|
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Consultant / Advisor | - |
Former positions of Rachel Belsham
| Companies | Position | End |
|---|---|---|
Visa Europe Ltd.
Visa Europe Ltd. Regional BanksFinance Operates digital payments network and issues credit and debit cards | Corporate Officer/Principal | - |
Training of Rachel Belsham
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Visa Europe Ltd.
Visa Europe Ltd. Regional BanksFinance Operates digital payments network and issues credit and debit cards | Finance |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Finance |
- Stock Market
- Insiders
- Rachel Belsham
















